Data / Form D filings / Cardax Pharmaceuticals Inc
Cardax Pharmaceuticals Inc: Form D filings
Cardax Pharmaceuticals Inc, a biotechnology company in Honolulu, HI, filed 2 Form D notices with the SEC between 2008 and 2010. The latest, on September 28, 2010, reports $550,000 sold of a $2 million offering to 4 investors.
Find out what Cardax Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2800 Woodlawn Drive, Suite 129, Honolulu, HI, 96822
- Phone
- (808) 457-1375
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2006
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1408223
The full lists. Form D filings in Hawaii: 59 rows, $5, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 28, 2010 | New notice | $2,000,000 | $550,000 | $1,450,000 | 4 | Sep 23, 2010 | sec.gov |
| Dec 23, 2008 | New notice | $4,800,000 | $600,000 | $4,200,000 | 1 | Dec 9, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David G. Watumull | Executive Officer, Director | |
| Frank J. Herringer | Director | |
| Frederic J. Pashkow | Executive Officer, Director | |
| Nicholas J. Mitsakos | Director |
Every Form D from the week of Sep 27, 2010 · All recent filings in Hawaii · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cardax Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.